PortfoliosLab logoPortfoliosLab logo
ELVN vs. MP
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

ELVN vs. MP - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Enliven Therapeutics Inc. (ELVN) and MP Materials Corp. (MP). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, ELVN achieves a 133.96% return, which is significantly higher than MP's 35.69% return.


ELVN

1D
1.44%
1M
-13.41%
YTD
133.96%
6M
71.57%
1Y
64.82%
3Y*
18.69%
5Y*
2.00%
10Y*

MP

1D
-5.11%
1M
3.55%
YTD
35.69%
6M
16.76%
1Y
211.59%
3Y*
45.90%
5Y*
16.72%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

ELVN vs. MP - Yearly Performance Comparison


2026 (YTD)202520242023202220212020
ELVN
Enliven Therapeutics Inc.
133.96%-31.56%62.57%-15.40%81.78%-89.80%-46.10%
MP
MP Materials Corp.
35.69%223.85%-21.41%-18.25%-46.54%41.19%221.70%

Correlation

The correlation between ELVN and MP is 0.09, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.09

Correlation (3Y)
Calculated over the trailing 3-year period

0.19

Correlation (5Y)
Calculated over the trailing 5-year period

0.18

Correlation (All Time)
Calculated using the full available price history since Jun 23, 2020

0.19

The correlation between ELVN and MP shifts across timeframes, from 0.09 (1 year) to 0.19 (3 years), reflecting how their relationship changes across market environments.

Fundamentals

EPS

ELVN:

-$1.69

MP:

-$0.53

Total Revenue (TTM)

ELVN:

$0.00

MP:

$305.30M

Gross Profit (TTM)

ELVN:

-$46.00K

MP:

$25.30M

EBITDA (TTM)

ELVN:

-$110.65M

MP:

$1.52M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

ELVN vs. MP — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ELVN
ELVN Risk / Return Rank: 7171
Overall Rank
ELVN Sharpe Ratio Rank: 6767
Sharpe Ratio Rank
ELVN Sortino Ratio Rank: 7474
Sortino Ratio Rank
ELVN Omega Ratio Rank: 6969
Omega Ratio Rank
ELVN Calmar Ratio Rank: 7272
Calmar Ratio Rank
ELVN Martin Ratio Rank: 7474
Martin Ratio Rank

MP
MP Risk / Return Rank: 8686
Overall Rank
MP Sharpe Ratio Rank: 9090
Sharpe Ratio Rank
MP Sortino Ratio Rank: 8989
Sortino Ratio Rank
MP Omega Ratio Rank: 8585
Omega Ratio Rank
MP Calmar Ratio Rank: 8787
Calmar Ratio Rank
MP Martin Ratio Rank: 8080
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ELVN vs. MP - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Enliven Therapeutics Inc. (ELVN) and MP Materials Corp. (MP). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


ELVNMPDifference
Sharpe ratioReturn per unit of total volatility

-1.47

Sortino ratioReturn per unit of downside risk

-1.23

Omega ratioGain probability vs. loss probability

1.22

1.36

-0.15

Calmar ratioReturn relative to maximum drawdown

1.77

3.96

-2.19

Martin ratioReturn relative to average drawdown

4.61

6.77

-2.15

ELVN vs. MP - Sharpe Ratio Comparison

The current ELVN Sharpe Ratio is 0.80, which is lower than the MP Sharpe Ratio of 2.27. The chart below compares the historical Sharpe Ratios of ELVN and MP, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


ELVNMPDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.80

2.27

-1.47

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.02

0.24

-0.22

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.09

0.53

-0.62

Drawdowns

ELVN vs. MP - Drawdown Comparison

The maximum ELVN drawdown since its inception was -98.20%, which is greater than MP's maximum drawdown of -81.99%. Use the drawdown chart below to compare losses from any high point for ELVN and MP.


Loading charts...

Drawdown Indicators


ELVNMPDifference

Max Drawdown

Largest peak-to-trough decline

-98.20%

-81.99%

-16.21%

Max Drawdown (1Y)

Largest decline over 1 year

-36.84%

-53.79%

+16.95%

Max Drawdown (3Y)

Largest decline over 3 years

-56.05%

-59.47%

+3.42%

Max Drawdown (5Y)

Largest decline over 5 years

-89.05%

-81.99%

-7.06%

Current Drawdown

Current decline from peak

-83.58%

-30.51%

-53.07%

Average Drawdown

Average peak-to-trough decline

-84.22%

-42.63%

-41.59%

Ulcer Index

Depth and duration of drawdowns from previous peaks

14.09%

31.40%

-17.31%

Volatility

ELVN vs. MP - Volatility Comparison

The current volatility for Enliven Therapeutics Inc. (ELVN) is 14.50%, while MP Materials Corp. (MP) has a volatility of 21.38%. This indicates that ELVN experiences smaller price fluctuations and is considered to be less risky than MP based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


ELVNMPDifference

Volatility (1M)

Calculated over the trailing 1-month period

14.50%

21.38%

-6.88%

Volatility (6M)

Calculated over the trailing 6-month period

60.61%

50.40%

+10.21%

Volatility (1Y)

Calculated over the trailing 1-year period

82.50%

93.94%

-11.44%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

85.81%

69.57%

+16.24%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

87.95%

72.60%

+15.35%

Dividends

ELVN vs. MP - Dividend Comparison

Neither ELVN nor MP has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

ELVN vs. MP - Financials Comparison

This section allows you to compare key financial metrics between Enliven Therapeutics Inc. and MP Materials Corp.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0050.00M100.00M150.00M202220232024202520260
90.65M
(ELVN) Total Revenue
(MP) Total Revenue
Values in USD except per share items

Frequently Asked Questions


ELVN and MP have a correlation of 0.09, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

MP has higher volatility (21.38%) compared to ELVN (14.50%). In terms of maximum drawdown, ELVN dropped -98.20% vs MP's -81.99%.

MP currently has the higher Sharpe Ratio (2.27 vs 0.80), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for ELVN and MP

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer